1/34
Looks like no tags are added yet.
basal cell carcinoma
pearly papule with telangiectasias
rolled borders central ulceration ("rodent ulcer")

surgical excision
first line treatment for BCC
face, recurrent, high-risk lesions
indications for mohs surgery
imiquimod, 5-FU
topicals for basal cell carcinomas superficial lesions
actinic keratosis
precursor of skin SCC

Sun exposure (UVB)
Actinic keratosis (precursor)
Immunosuppression (transplant patients)
Chronic wounds/scars (Marjolin ulcer)
HPV (especially genital SCC)
Smoking (lip/oral SCC)
risk factors of skin SCC
Marjolin ulcer
SCC arising from chronic wound such as previous burn scar, tends to be very aggressive
genital SCC
HPV is a risk factor for this type of skin cancer
Scaly, erythematous plaque or nodule
May ulcerate or bleed
clinical appearance of SCC
cryotherapy, 5-FU
treatment for actinic keratosis
Intermittent intense sun exposure / blistering sunburns ⭐
Fair skin, light eyes
Multiple or atypical nevi
major risk factors for melanoma
CDKN2A (p16)
genetic marker associated with familial melanoma
BRAF mutations
mutation associated with sporadic melanoma
pancreatic cancer
cancer associated with familial melanoma syndrome
dysplastic nevi
atypical moles that can develop into skin cancer
asymmetry, border, color, diameter, evolution
define the ABCDE appearance of melanoma
>6 mm
diameter associated with melanoma
breslow thickness
most important prognostic factor for melanoma
Breslow thickness
measures depth of tumor invasion in mm
low risk breslow depth
1-2 mm
intermediate risk breslow depth
>4mm
high risk breslow depth
Surgical margins
Need for sentinel lymph node biopsy
clinical implications of breslow depth
Clark Levels of Melanoma Staging
I: intraepidermal
II: in papillary dermis
III: fills papillary dermis
IV: reticular dermis
V: enters subcutaneous tissue
familial melanoma + pancreatic cancer
CDKN2A mutation is associated with
0.5-1 cm
recommended surgical margins for in situ melanoma
2cm
recommended surgical margins for >2mm depth
Mohs is NOT standard (except select in situ cases on face)
is Mohs standard therapy for all skin cancers?
Breslow ≥1.0 mm ⭐
0.8-1.0 mm WITH ulceration or high-risk features
indications for sentinel node biopsy in skin cancer
immunotherapy:
PD-1 inhibitors
first line medical treatment of metastatic melanoma
Immunosuppressed patients = dramatically increased risk
-esp with SCC
why do transplant patients have a higher risk of skin cancer
merkel cell carcinoma
rare, aggressive neuroendocrine skin cancer

Merkel Cell Carcinoma
Painless, rapidly growing violaceous nodule ⭐
Often on sun-exposed areas (head/neck)
Wide local excision + SLNB ⭐
Radiation therapy (often used)
Immunotherapy for advanced disease
treatment for merkel cell carcinoma
systemic therapy, NOT automatic dissection
mgmt of a positive sentinel lymph node biopsy